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ABSTRACT 
 
Rotavirus (RV) infections cause severe life threatening diarrhea in young 
children and immunocompromised individuals.  Several effective vaccines have 
been developed for young children but are not protective against all strains of RV, 
and there are no anti-RV therapeutics. Our laboratory has discovered a decrease 
in the number of infectious simian RV particles (SA114f) in human intestinal cell 
line, HT29.f8 cells with the addition of either of two stilbenoids, arachidin-1 (A1) or 
arachidin-3 (A3). This suggests effects on the host cell and RV replication.  We 
examined the cellular effects of human RV strain (Wa) on a human intestinal cell 
line (HT29.f8) and an African green monkey kidney cell line (MA104) treated 
with/without either arachidin. Both cell lines demonstrated apoptotic characteristics 
that were modulated with the addition of either A1 or A3, and the size and 
population of the released virus particles were significantly altered. Likewise, the 
number of infectious virus particles released from the arachidin treated cells were 
significantly reduced.  This data supports the RV therapeutic potential of A1 and 
A3. 
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INTRODUCTION 
 
 
 
Rotavirus 
 
 
Rotavirus (RV) is a major cause of infantile gastroenteritis, which accounts 
for 20% of deaths in children less than 5 years of age. RV also causes severe 
diseases in pediatric and adult immunocompromised individuals, patients on 
chemotherapy, and transplantation patients.  RV belongs to the family Reoviridae 
that infects humans and several other mammals including cattle, pigs, mice, and 
primates (Desselberger, 2014; Hall, Bridger, Chandler, & Woode, 1976; Mebus et 
al., 1976).  The ubiquitous nature of RV and the health risks it poses for a wide 
range of hosts has made it a heavily studied pathogen for the past 70 years.  One 
of the earliest studies dates to 1943 at Johns Hopkins University in Baltimore.  
Gnotobiotic calves were inoculated with stool samples from children experiencing 
gastroenteritis.  Although the technology to identify the infectious agent was not 
available at that time, signs and symptom of lethargy and watery diarrhea were 
observed in the calves.  In later years with the development of transmission 
electron microscopy (TEM), micrographs of intestinal epithelium from infant mice 
with diarrhea demonstrated spherical particles that were about 75 nm in diameter 
(Adams & Kraft, 1963).  In 1973, stool samples from several severe gastroenteritis 
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cases in young children at the Royal Children’s Hospital in London, England were 
submitted for electron microscopy (EM), and the same type of spherical particles 
observed by Adams and Kraft were detected (Bishop, Davidson, Holmes, & Ruck, 
1973).  It was the first confirmation in humans and led to further use of EM for 
diagnostics of RV infections.  Preserved fecal samples from the 1943 study by 
Light and Hodes were viewed with EM in 1976 and “reovirus” like particles were 
seen (Light & Hodes, 1943; Mebus et al., 1976).  Since then polyacrylamide gel 
electrophoresis (PAGE), enzyme linked immunosorbent assays (ELISA), and latex 
agglutination tests have been developed as more rapid and sensitive assays to 
test for RV infections. 
Globally, where temperature varies according to seasonality, RV is more 
common in the cooler months, but the seasonal peaks of the infections can vary 
broadly (Cook, Glass, LeBaron, & Ho, 1990). This seasonality is not well 
understood and is uncommon among most enteric pathogens. It became 
increasingly important to discover epidemiological patterns of RV infections.  One 
study looked at RV contaminated freshwater and its ability to maintain infectious 
RV particles (Rzeżutka & Cook, 2004). It was discovered that at 20°C, RV 
remained infectious for approximately 10 days; however, at 4°C the virus was 
infectious for 32 days.  Another study examined the occurrence of nosocomial RV 
infections.  Fingertips of healthy individuals were inoculated with the human RV 
strain (Wa) and the survival of the virus was monitored at multiple time points for 
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260 minutes (Rzeżutka & Cook, 2004).  It was found that RV retains infectivity for 
several hours on skin, and can remain infectious on various clinical and 
environmental fomites.  This indicates sterility and aseptic techniques are 
extremely important for care of newborns in hospital settings as they are highly 
susceptible to RV infections (Berardi et al., 2009). Furthermore, RV-infected 
infants can begin showing symptoms within 1-2 days after birth, exhibiting watery 
diarrhea, vomiting, and fever that can last 4-8 days (Bernstein, 2009). Trans 
placental antibodies are passed from mother to infant at the time of birth, however, 
these maternally derived IgG antibodies provide limited protection and will be 
absent in the child by five months of age (Bobek et al., 2010).  
There have been up to 600,000 deaths associated with RV infections per 
year worldwide, with the majority of the deaths occurring in Africa and Asia 
(Bernstein, 2009; Parashar & Glass, 2009).  RV is transmitted by the fecal-oral 
route and is extremely contagious during the diarrheal stage of infection (Cook et 
al., 1990).  Once infected a person can remain asymptomatic or have an acute 
gastroenteritis (AGE) with mild to severe diarrhea, and vomiting.  This combination 
of symptoms leads to a massive electrolyte imbalance causing severe dehydration.  
Dehydration and cardiac failure are the main causes of death due to RV infections 
(Desselberger, 2014; Tate et al., 2012).  According to the Centers for Disease 
Control (CDC) and the World Health Organization (WHO), the fatality rates 
associated with diarrheal disease have fallen sharply since 1980, due to the aid of 
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RV vaccines and effective treatment practices (Bishop, 2009; Jiang, Jiang, Tate, 
Parashar, & Patel, 2010).  However, recently there have been 114 million RV 
diarrheal episodes worldwide per year (Greenberg & Estes, 2009).  Of these 
cases, approximately 2.4 million are hospitalized and over 500,000 children under 
the age of five succumb to the RV infection (Greenberg & Estes, 2009).  Although 
the RV disease burden has been significantly decreased in Western Europe and 
the United States, both countries reported that 50% of gastroenteritis emergency 
cases presented in children were caused by RV infections (Greenberg & Estes, 
2009).  
In 1973, RV particles were visualized using EM by Ruth Bishop and her 
colleagues at the Department of Medicine, Melbourne University, Australia (Bishop 
et al., 1973).  One of her collaborators, Thomas Flewett, and his team suggested 
the Latin name rota, meaning wheel, due to its unique microscopic appearance 
(Flewett & Woode, 1978). Four years later, the International Committee on 
Taxonomy of Viruses agreed to officially name the pathogen, rotavirus (Matthews, 
1979).  Infectious RV particles (virions) are approximately 75-80 nanometers in 
diameter, non-enveloped, with three concentric icosahedral protein layers that 
encapsulate 11 double stranded RNA segments.  RV structure is composed of 
three structural, viral proteins, VP2, VP6 and VP7.  The inner core or single layered 
particle is made up of 60 dimers of VP2.  This layer encloses the complete viral 
genome as well as viral RNA dependent RNA polymerase, VP1 and the capping 
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enzyme VP3 (Desselberger, 2014; Patton, 1995; Payne et al., 2006). The 
intermediate capsid layer is composed of VP6 and is arranged in lattice form with 
260 trimers forming its icosahedral layer. Immature virus particles with only VP6 
as their outside protein coat are typically referred to as noninfectious double 
layered particles (DLPs) however they are transcriptionally competent during the 
replication process.  The outermost layer consists of an icosahedral capsid made 
of VP7.  One unique feature of rotavirus particles is the presence of large channels 
that penetrate through the VP7 and VP6 layers, allowing for the passage of 
aqueous materials in and out of the capsid (Payne et al., 2006).  When an RV 
particle contains VP4 and VP7, it is considered a triple layered particle (TLP) and 
is infectious due to 60 projecting spikes that are made up of VP4 dimers used by 
virions for cell entry (D. Payne et al., 2006).  When RV particles make contact with 
a host cell they attach with VP4 before it is cleaved by trypsin present in the small 
intestine.  This produces a conformational change leading to the production of VP5 
and VP8 that are necessary for viral entry into the host (M K Estes, Graham, & 
Mason, 1981).  Low calcium levels in endosomes make it possible for direct 
membrane penetration due to the removal of the outer capsid protein, VP7 
(Desselberger, 2014).  The newly assembled  DLPs are released into the 
cytoplasm of the infected cell and are transcriptionally active (Gardet et al., 2006).  
Once DLPs have made their way to a specialized structure called the viroplasm, 
viral replication begins to take place (Patton, 1995).  Viroplasms are usually 
6 
 
 
adjacent to the nucleus and can vary in shape and size depending on the stage of 
the replication cycle (Desselberger, 2014).  After new DLPs have been produced 
they bind to NSP4 found on the endoplasmic reticulum (ER).  As VP4 and VP7 
assemble, the ER membranes are removed, resulting in a mature TLP (Greenberg 
& Estes, 2009). Mature virions are released by lysis (McNulty et al,1976), or they 
can be delivered to the plasma membrane in polarizing cells.    
There are two licensed RV attenuated vaccines, RotaTeq® (Merck) and 
Rotarix® (GlaxoSmithKline) in the United States, that prevent severe diarrhea, and 
Rotavac® which was recently released in India by Hyderabad-based Bharat 
Biotech International. However, the vaccines’ efficacies are dependent on the 
timing of vaccination, and are designed to protect against common RV strains in 
specific areas of the world.  Consequently, they are dependent on the genetic 
stability of the virus with rearrangements randomly occurring resulting in new 
infectious RV strains. Furthermore, the vaccines are contraindicated for 
immunosuppressed individuals, and there are no antiviral therapeutic agents 
currently available for RV infections.  Besides the possibility of contracting RV-
induced diarrhea directly from the attenuated vaccines, there are documented 
cases of horizontal transmission of vaccine RV among immunocompromised 
household contacts from vaccinated children who shed the vaccine virus.  RV 
vaccines have been introduced in many countries around the world; however, it 
still remains an important cause of mortality in children. 
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 Recent studies in the Parr laboratory have shown that stilbenoids, natural 
products from peanut hairy root cultures, notably decrease the production of 
infectious RV particles and significantly affect RV replication (Ball et al., 2015).  
This demonstrates the potential for the development of these stilbenoids as 
antiviral therapeutics. 
Stilbenoids 
Stilbenoids are secondary metabolites that act as phytoalexins produced by 
plants such as grapes, berries, and peanuts in response to pathogens (Huang et 
al., 2010; Moss et al., 2013). Phytoalexin substances synthesized by plants 
accumulate rapidly at areas of infections and demonstrate anti-oxidative properties 
(Chong et al., 2009; Jeandet et al., 2010). 
Resveratrol, a common stilbenoid, has received a great deal of interest due 
to its wide range of biological activities with potential impact on human health, 
including anti-oxidant, anti-inflammatory, cardio protective, antiviral, anticancer, 
and anti-aging properties (Huang et al., 2010; Sobolev et al., 2006; Velayudhan et 
al., 2014).  Many in vitro and in vivo studies have demonstrated significant, 
advantageous, biological effects of resveratrol  (Berardi et al., 2009; Nakamura et 
al., 2010; Palamara et al., 2005), however due to limited oral bioavailability, 
resveratrol does not live up to its full potential (Gambini et al., 2015; Vitaglione et 
al., 2005). This may be due to rapid absorption and metabolism leading to the 
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formation of various metabolites such as resveratrol glucuronides and sulfates  that 
are quickly released from the body (Gambini et al., 2015; Vitaglione et al., 2005).  
In peanuts, the majority of the known stilbenoids are prenylated, harboring an 
isopentenyl, hydrophobic moiety as in A1 and A3 (Sobolev et al., 2006).   
Arachidins 
Peanut (Arachis hypogaea) hairy root cultures produce multiple stilbenoids 
upon their exposure to abiotic (environmental) and biotic (caused by living 
organisms) stresses (Chong et al., 2009). Among these compounds the analogues 
of piceatannol and resveratrol, A1 and A3, respectively, possess anti-
inflammatory, anti-cancer and anti-proliferative properties similar to resveratrol 
(Chang et al., 2006; Djoko et al., 2007). 
One study suggests that the increased therapeutic activity of these natural 
products likely results from the increased ability to dissolve fats, oils, and non-polar 
solvents imparted by single or multiple prenyl groups present within their structure 
(Huang et al., 2010).  It was proposed that the greater lipophilicity of the prenylated 
arachidins may allow for easier interaction between these substances and cell 
membranes. This would enhance associations with potential membrane-bound 
molecular targets responsible for the beneficial actions of these compounds 
(Huang et al., 2010).  Another study suggests that the lipophilic side chain (3-
methyl-1-butenyl group) might hinder the addition of glucuronic acid to a substrate 
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and thereby slow metabolism which enhances the bioavailability of the analogues 
piceatannol or resveratrol, A1 and A3 (Brents et al., 2012).  Additionally, A3 also 
exhibits higher biological activities both in vitro when compared to resveratrol,  as 
well as  demonstrating  antiviral activity (Ball et al., 2015). 
Our first paper summarizes the progression of the RV infection with and 
without the arachidins using a time course study at 12, 14, 16, and 18 hours post 
infection (hpi) in a human intestinal cell line, HT29.f8.  Cell ultrastructurewas 
characterized and morphometric analysis of maturing virus particles were 
performed using transmission electron microscopy (TEM). Progeny infectious RV 
particles were measured using plaque forming assays (PFUs).  At the same time 
points, released virus particles were evaluated for concentration and size 
distribution by tunable resistive pulse sensing (TRPS) analysis with the qNano 
instrument (IZON).  Furthermore, the nucleus to cytoplasmic ratios were measured 
to observe the cells’ progression to apoptosis.  While performing the study on 
nucleus to cytoplasm ratios the presence of autophagosomes were reported to 
note the regulation and cross talk between apoptosis and autophagy. Likewise, 
qRT-PCR experiments were implemented to determine which transcripts 
associated with apoptosis and autophagy are being modulated with the addition of 
the arachidins.   
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CHAPTER ONE 
 
 
 
A TIME COURSE STUDY OF ROTAVIRUS-INFECTED CELLS TREATED 
WITH STILBENOIDS AND THE REGULATION OF CELL DEATH PATHWAYS 
 
Caleb M Witcher1, Hannah N Lockwood1,2, Rebekah Napier-Jameson1, Macie 
N Mattila1, Essence B Strange1, Josephine Taylor1, Beatrice Clack1, Fabricio 
Medina-Bolivar3, Judith M Ball3 and Rebecca D Parr1*   
 
1 Department of Biology, Stephen F Austin State University, Nacogdoches, TX 75962; 2 
Hannah N. Lockwood, Tyler, TX, 3 Department of Biological Sciences & Arkansas 
Biosciences Institute, Arkansas State University, Jonesboro, AR 72401; 4 Department of 
Biological and Environmental Sciences, Texas A&M University-Commerce, Commerce, 
TX 77843, *e-mail: parrr1@sfasu.edu 
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ABSTRACT 
Rotavirus (RV) infections cause severe diarrhea in young animals, children and 
immunocompromised individuals. Two vaccines for young children have been 
developed that are effective in reducing symptoms of specific RV strains commonly 
found in the United States, but are not protective against diarrhea caused by 
certain RV strains in other areas of the world.  Therefore, understanding the 
mechanisms of RV pathogenesis, along with how the host responds to RV 
infections, will support the discovery of new strategies to use against RV infections.  
Our laboratory has shown that two natural products from peanut hairy root cultures, 
arachidin-1 (A1) and arachidin-3 (A3), significantly inhibit simian RV (SA114f) 
replication.  Although the molecular mechanism(s) of action are not known, the 
decrease in infectious virus particles suggests antiviral activity. The objectives of 
this study were to determine if the arachidins have the same effects on a human 
(Wa) RV infection as previously described with the simian RV, and to perform a 
time course analysis of the changes in RV-infected cells and RV particles.  Cell 
viability assays showed the arachidins alone had no effect on the cells, and virus 
plaque assays demonstrated a significant decrease in virus progeny similar to the 
simian RV study. Transmission electron microscopy (TEM) was used to observe 
the gross distribution of RV particles and the effects on cell ultrastructure. Two 
populations of significantly different sizes of RV particles were measured. A time 
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course of the ratios of the nucleus to the cytoplasm in RV-infected cells was 
compared to the ratios of RV-infected cells with the addition of the arachidins. Cells 
treated with the arachidins displayed an ultrastructure similar to control cells by 18 
hpi. Tunable resistive pulse sensing technology (TRPS) was used to quantify and 
determined the distribution of sizes of all the virus particles in the supernatants of 
the treated and untreated cells at each time point.  Supernatants collected from 
arachidin treated cells revealed a shift in population from non-enveloped, mature 
RV particles to enveloped particles by 18 hpi. Furthermore, slot blot assays of the 
HT29.f8 cell lysates demonstrate the presence of both cannabinoid receptors 1 
and 2 which have been shown to bind to both A1 and A3.  Taken together, these 
data demonstrate that Wa RV replication in HT29.f8 cells was affected by A1 and 
A3, with consistent patterns in cell morphology throughout the time course. The 
mechanism of action may be through binding of the arachidins to the cannabinoid 
receptors, however, the prominence of autophagosomes in A1 treated cells, but 
not in cells treated with A3 suggests different signaling pathways are activated. 
The arachidins appeared to hinder the progress of the RV infection, thus showing 
promise to be RV therapeutic agents. 
 
 
Keywords: rotavirus, arachidin-1, arachidin-3, apoptosis, autophagy 
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1. Introduction 
Rotavirus (RV) is one of the leading causes of severe gastroenteritis in 
infants and young children around the world (Bernstein, 2009; Stokley et al., 2014; 
World Health Organization, 2013).  RV is in the family Reoviridae and infects 
humans and several mammals.  The ubiquitous nature of RV and the health risks 
it poses for a wide range of hosts has made it a heavily studied pathogen for the 
past 70 years. With the development of transmission electron microscopy (TEM), 
micrographs of intestinal epithelium from infant mice with diarrhea demonstrate 
spherical particles that ranged from 65 to 75 nm in diameter and are identified as 
reo-like viruses (Adams & Kraft, 1963).  
RV-infected infants can begin showing symptoms within 1-2 days after birth, 
exhibiting watery diarrhea, vomiting, and fever that can last 4-8 days (Bernstein, 
2009).  While trans placental antibodies transfer from mother to infant at the time 
of birth; these maternally derived IgG antibodies provide limited protection and will 
be absent in the child by 5 months of age (Bobek et al., 2010).  RV is transmitted 
by the fecal-oral route and is extremely contagious during the diarrheal stage of 
infection (Cook et al., 1990).  Once infected, a person can remain asymptomatic 
or have acute gastroenteritis (AGE) with mild to severe diarrhea, and vomiting. 
This combination of symptoms leads to a massive electrolyte imbalance causing 
severe dehydration.  Dehydration and cardiac failure are the main causes of death 
14 
 
 
due to RV infections (Desselberger, 2014; Tate et al., 2012). Worldwide, there are 
only three licensed live vaccines available that prevent severe diarrhea; however, 
they are only effective against specific strains (Bhandari et al., 2014; Glass et al., 
2014). Furthermore, the zoonotic nature of RV infections supports the likelihood 
that reassortment events will take place, decreasing the efficacy of the vaccines 
and warranting the need for novel therapeutic agents against RV infections 
(Desselberger, 2014).1 
Our laboratory is investigating the effects of highly purified prenylated 
stilbenoids extracted from peanut (Arachis hypogea) hairy root cultures on RV 
infections (Ball et al., 2015).  Previously, four stilbenoids were tested and the two 
prenylated stilbenoids, arachidin-1 (A1) and arachidin- 3 (A3), were shown to 
significantly inhibit the production of infectious simian RV (SA114f) virions (Ball et 
al., 2015).  Stilbenoids are secondary metabolites derived from plants, such as 
grapes, berries and peanuts, that have antioxidant, anticancer, antifungal and anti-
inflammatory properties (Aggarwal et al., 2004; Athar et al., 2007; Roupe et al., 
2006). They are phytoalexins that are produced de novo in plants in response to 
environmental stresses and accumulate rapidly at areas of pathogen infections 
                                                          
 
1 Abbreviations: Rotavirus (RV), Plaque forming units (PFU), hours post infection (hpi), dimethyl 
sulfoxide (DMSO), fetal bovine serum (FBS), Dulbecco’s Modified Eagle’s medium (DMEM), 
arachidin-1 (A1), arachidin-3 (A3), multiplicity of infection (MOI), tissue culture (TC), MSV 
(modified Murashige and Skoog medium), phosphate buffered saline (PBS), analysis of variance 
(ANOVA), transmission electron microscopy (TEM), tunable resistance pulse sensing (TRPS), 
endoplasmic reticulum (ER), plasma membrane (PM). 
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(Hammerschimidt & Dann, 1999; Huang et al., 2010; Moss et al., 2013).  Although 
the molecular mechanism(s) of action for A1 and A3 on RV infections are unknown, 
the decrease in infectious virus particles suggests an effect on viral maturation and 
replication.  Earlier studies demonstrated that RV dampens the innate immune 
response via modulation by NSP1 (Holloway & Coulson, 2013).  This study 
investigated the effects of A1 and A3 on the clonally derived human intestinal cell 
line, HT29.f8, infected with the human RV strain, Wa. 
Virus plaque forming assays were performed to quantify and compare the 
amount of infectious RV particles produced in human RV Wa-infected MA104 cells 
with and without A1 or A3.  Tunable resistive pulse sensing technology (TRPS) 
using the qNano system by Izon was employed to quantify and determine the size 
distribution of all the virus particles in arachidin-treated and untreated HT29.f8 
cells.  Likewise, morphometric analyses of the cellular ultrastructure and gross 
distribution of RV particles was performed using transmission electron microscopy 
(TEM).  This study demonstrated that A1 and A3 decreased the number of Wa, RV 
infectious virus particles produced.  The size of the population of RV particles 
shifted from that of infectious RV particles to that of larger immature RV particles 
with arachidin treatment. These sizes correspond to the measured enveloped and 
non-enveloped RV particles observed in the cells. Also, changes in cell structure 
were observed that are characteristic of apoptosis and autophagy, and HT29.f8 
cells were shown to be positive for both cannabinoid receptor 1 and receptor 2.  
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This study suggests a mechanism of action of the arachidins on RV-infected 
intestinal cells and the potential anti-RV therapeutic activity of A1 and A3.  
2. Materials and Methods 
2.1 Cells, Virus, Reagents and Bioproduction of Stilbenoids 
2.1.1 Cell Lines and Virus 
MA104 cells were obtained from ATCC (Rockville, MD) and the HT29.F8 
cells, a spontaneously polarizing cell line, were derived from the parent human 
adenocarcinoma (HT29) intestinal line (Mitchell & Ball, 2004). The cell line was 
confirmed to be free of mycoplasma contamination using the MycoFind 
mycoplasma PCR kit version 2.0 (Clongen Laboratories, LLC).  RV Wa (G[1] P[8] 
genotype) (Matthijnssens et al., 2008) was amplified, viral titers determined by 
plaque forming unit (PFU) assays in MA104 cells, and stored at -80°C. Arachidin 
efficacies against RV were tested using HT29.f8 cells obtained from Dr. Judith Ball 
(Texas A&M University, College Station, Tx).  The cell line was maintained in 
Dulbecco's Modified Eagle Medium (DMEM; Gibco, Grand Island, NY) 
supplemented with 5% fetal bovine serum (FBS), glutamine (2 mM), penicillin-
streptomycin (100 µg/mL) and non-essential amino acids (1X) (Sigma, St. Louis, 
MO) (Mitchell & Ball, 2004).   
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2.1.2 Bioproduction of stilbenoids in peanut hairy root cultures 
A1 and A3 were purified from methyl-β-cyclodextrin (CD)-elicited peanut (A. 
hypogea) hairy root cultures as recently described (Abbott et al., 2010; Condori et 
al., 2010; Yang et al., 2015).  Briefly, 9-day peanut hairy root cultures, line 3 
(Condori et al. 2010), were elicited with methyl-β-cyclodextrin (fresh MSV medium 
with 9 g/L methyl-β-cyclodextrin (Cavasol® W7 M)) (Medina-Bolivar et al. 2007; 
Medina-Bolivar et al. 2010). Cultures were incubated in the dark at 28oC for an 
additional 72 hours to induce synthesis and secretion of stilbenoids into the culture 
medium (Abbott et al., 2010; Yang et al., 2015).  After the elicitation period, the 
culture medium was removed from each flask and combined. This pooled medium 
was mixed with an equal volume of ethyl acetate in a separator funnel to extract 
the stilbenoids as described previously (Jose Condori et2 al., 2010).  The ethyl 
acetate phase was recovered and dried in a rotavapor (Buchi), and A1 and A3 was 
purified from the extract with HPCCC.  Fractions were collected every 30 seconds, 
dried in a speed-vac and selected fractions were checked for purity by mass 
spectrometry using an UltiMate 3000 ultrahigh performance liquid chromatography 
(UHPLC) system (Dionex, Thermo Scientific) coupled with a LTQ XL linear ion trap 
mass spectrometer (Thermo Scientific) as previously described (Marsh et al., 
2014).  HPCCC fractions containing A1 and A3 with over 95% purity based on 
HPLC analysis (UV 340 nm) were combined, dried under a nitrogen stream and 
used for viral assays.  The dry mass of the purified stilbenoids were reconstituted 
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in 0.02% DMSO with 1 µg/ml trypsin (Worthington Biochemical, Lakewood, NJ) in 
MEM medium.  
2.2 Viability Assay 
Viability assays were performed with RV alone, RV with 0.002% DMSO, RV 
with 20 µM A1 or A3, A1 alone, A3 alone, and cells without treatments (NV-no 
virus) using the trypan blue cell exclusion assay (Ball et al., 2015; Freshney, 1994).  
Briefly, HT29.f8 cells were grown to 80% confluence in 6-well tissue culture plates 
(Corning Life Sciences); starved for fetal bovine sera 12 hours prior to the addition 
of DMSO, DMSO with 20 µM concentrations of the arachidins, RV and RV with 20 
µM concentrations of the arachidins.  At 18 hours after the treatments, a 
suspension of ~106 cells/mL was diluted 1:1 with a 0.4% trypan blue solution, and 
loaded onto a hemocytometer.  The number of stained dead cells and total number 
of cells were counted, and the calculated percentage of live cells was reported. 
Each treatment was performed in triplicate, data was expressed as the mean  1 
standard deviation (SD), and comparisons were statistically evaluated by analysis 
of variance (ANOVA) and Student t tests using Excel (significance level, p ≤ 0.05). 
2.3 RV Infections in HT29.f8 Cells 
To test the biological activity of A1 and A3 on RV infections in HT29.f8 cells, 
the cells were grown to 80% confluence in T25 tissue culture flasks (Corning Life 
Sciences); starved for fetal bovine sera 12 hours prior to infection, and then 
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infected with RV Wa as previously described (Arnold et al., 2009; Ball et al., 2015; 
Yakshe et al., 2015).  Briefly, Wa RV stock was sonicated 5 minutes using a cup 
horn attachment and ice bath in a Misonix Sonicator 3000 (Misonix, Inc, 
Farmingdale, NY) and incubated in serum-free DMEM with 1 μg/mL trypsin 
(Worthington Biochemical, Lakewood, NJ) for 45 min at 37°C. The activated viral 
inoculum was incubated with the cells for 1 hour at 37°C in 5% CO2 at an MOI of 
0.002. At the scheduled collection times, cells were washed with PBS and released 
from the flasks using a 0.25% trypsin-EDTA solution. The supernatants were 
collected, clarified at 300xg for 5 minutes, and stored at -80°C for plaque assays 
and TRPS analysis (see below).  The cells were washed in 1X cold Dulbecco's 
PBS (Caisson Laboratories, Smithfield, UT), fixed with 5% glutaraldehyde and 
used for TEM analysis as described below.  
2.4 Infectious RV particle quantification 
Plaque forming unit (PFU) assays were performed in triplicate as previously 
described (Arnold et al., 2009; Ball et al., 2015; Yakshe et al., 2015).  Briefly, 10-
fold dilutions of RV alone and RV with 20 µM of A1 or A3 were added to serum 
starved MA104 cells for 1 hour. The virus inoculum was replaced with 3 mL of a 
medium overlay consisting of a 1:1 mixture of 1.2% agarose (Apex Low Melting 
Point Agarose, Genesee Scientific Inc) and complete MEM containing 0.5 μg/mL 
trypsin and incubated at 37°C in 5% CO2 for 3 to 4 days or until plaques became 
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visible.  A neutral red overlay consisting of a 1:1 mixture of 1.2% agarose with an 
equal volume of serum-free MEM containing 50 μg/mL neutral red was prepared 
and 2 mL per well of stain overlay was added on top of the first agarose/medium 
overlay. The six-well plates were incubated at 37°C until plaques were visible 
(approximately 3 to 4 days).  The individual plaques were counted, and the titers 
were calculated as follows:  Number of plaques x 1/dilution factor x 1/ (mL of 
inoculum) = PFU/mL.  Plaque forming assays were performed in triplicate as 
outlined above.  Data were expressed as mean  SD, and comparisons were 
statistically evaluated by analysis of variance (ANOVA) and Student t tests using 
Excel (significance level, p ≤ 0.05). 
2.5 Morphometric analysis of Arachidin Treated RV-infected HT29.f8 cells 
TEM analysis was performed on RV-infected HT29.f8 cells to visualize the 
effects of A1 and A3 on progeny virus and cellular morphology as described by 
Wright (2000).  Briefly, RV-infected HT29.f8 cells with and without 20 µM A1 or A3 
were incubated for 12, 14, 16 and 18 hpi, washed with PBS and then trypsinized.  
Cells were pelleted and fixed with 5% glutaraldehyde and refrigerated overnight. 
The cells were post-fixed with 2% osmium tetroxide followed by an overnight 
incubation in a uranyl acetate solution. Cells were dehydrated with a graded 
ethanol series, and acetone was used for the transitional solvent, then samples 
were infiltrated and embedded in Spurr’s resin. Thin sections were obtained with 
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an RMC MT-X ultra-microtome and stained with uranyl acetate and lead citrate. 
Samples were examined and photographed  with a Hitachi H-7000 transmission 
electron microscope operating at 75 KeV (Wright, 2000), negatives were digitized 
at 800 dpi, and image analysis was performed using Macnification Version 2 
(Orbicule, Inc., www.orbicule.com). The mean ratio of the cell nucleus to cytoplasm 
was determined using 10 micrographs of cells from each treatment to compare 
between test and control groups.  The average diameter of enveloped and non-
enveloped RV particles was determined (n=23 for each group).  Ten micrographs 
of cells from each treatment at all four time points (see above) were scored for 
presence or absence of autophagosomes. 
2.6 Quantification and Size Distribution of RV Particles 
After observing enveloped RV (eRV) and non-enveloped RV (neRV) particles 
with TEM, TRPS analysis using the qNano system (Izon Science, Cambridge, MA) 
was performed on the RV-infected cell supernatants to display the concentration 
of virus particles/mL, diameter of RV particles and size distribution of particles.  
TRPS is based on a coulter counter that is composed of two fluid reservoirs filled 
with an electrolyte or other conductive medium and separated by a membrane 
containing a nanopore (Kozak et al., 2011; Weatherall et al., 2016).  When an 
electrical field is applied across the pore, the resistance to the resulting ionic 
current is indirectly proportional to the cross-sectional area of the pore.  When a 
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non-conducting particle passes through the pore, the increase in resistance is 
proportional to the particle volume relative to pore size. This change in resistance 
is detected as a pulse in an ionic current. The pulse frequency is proportional to 
particle flow rate and particle concentration (DeBlois, 1970). This system provides 
a quick and accurate way to measure sizes of individual nanoparticles and their 
volume in a solution.  All qNano experiments were performed using the 
manufacturer's established protocols (Bo et al., 2014; Jones, 2015; Vogel et al., 
2011).  Briefly, prior to measuring, samples were purified using a qEV size 
exclusion column from Izon, and were suspended in PBS with 0.025% Tween 20 
to reduce particle aggregation and ease the wetting of the nanopore. A 1:1000 
dilution of the sample was placed on the qNano size-tunable nanopore (NP100, 
Izon) and each sample was measured as a transient change in the ionic current 
flow. This was denoted as a blockade event with its amplitude representing the 
blockade magnitude.  Because the blockade magnitude is proportional to the 
particle size, accurate particle sizing was achieved after calibration with particles 
of a known size (CPC100B, Izon) using identical settings. The size distribution and 
concentration analysis was performed using IZON proprietary software v3.2.2.268 
(Izon). 
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2.7 Quantification of Transcripts for Cell Death Pathway genes in HT29.f8 Cells 
The structural changes observed by TEM were validated by quantitative 
real-time polymerase chain reaction (qRT-PCR) assays.  RNA was extracted from 
each experimental set described above. The PureLink RNA Mini Kit (Ambion by 
Life Technologies; Foster City, CA) was used to extract and purify total RNA 
according to the manual protocol (Chirgwin et al., 1979; Vogelstein & Gillespie, 
1979).  Briefly, an equal volume of 70% ethanol was added to 5 µg of total RNA of 
each sample and vortexed. The samples were then transferred to a spin cartridge 
and centrifuged for 15 seconds at 12,000xg at room temperature. Then the sample 
was washed and centrifuged with 700 μL of wash buffer I for 15 seconds at 
12,000xg.  A second wash was performed with 500 μL of wash buffer II for 15 
seconds at 12,000xg. A final spin was performed at 12,000xg for 2 min to dry the 
membrane containing the bound RNA. The RNA was eluted from the membrane 
with 50 μL of nuclease free water. Total RNA was analyzed using a full spectrum 
analysis at 240 nm-320 nm in the Cary 50 spectrophotometer (Agilent, Corp.). The 
total RNA was stored at -80C for future studies. A conversion factor of 40 μg/mL 
was used to convert the A260 to concentration and the value of 10 corrected for 
path length of 0.1 mm (Sean and Wiley, 2008). The concentration of RNA was 
calculated using the formula as follows: Concentration of RNA= A260 x 40 μg/mL 
x 10 x Dilution factor. cDNA was then synthesized using the Thermo Scientific 
Verso cDNA Synthesis Kit from each experimental set using 5 μg of purified total 
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RNA.  A Master Mix was prepared as described in the manufacturer’s protocol as 
shown in Table 1 (2015 Thermo Fisher Scientific, Inc.). The samples were then 
placed into the BioRad Real-Time System C1000 Thermal Cycler Instrument 
(Hercules, CA) for the following cycle (Table 2). 
The qRT-PCR experiment was performed using a CFX96 Touch Real-Time 
PCR Detection System (BioRad, Des Plaines, IL).  For all experiments, reactions 
were performed in triplicate with Apex qPCR GREEN Master Mix without ROX 
(Genesee Scientific) that contained all necessary components to perform a DNA-
binding dye base real-time DNA amplification experiment (Table 3).  Primers were 
purchased from Sigma-Aldrich (St. Louis, MO) with the sequences, Tm, and base 
pairs sizes of the products shown in Table 4. 
Each reaction mixture contained 10 L of Apex qPCR GREEN Master Mix, 
0.5 L of 10 M forward/reverse primers, 3 L template cDNA and nuclease-free 
water to a final volume of 20 L.  GAPDH and -actin were used as housekeeping 
genes to normalize for relative expression analyses. The cycle threshold (Ct) value 
or cycle number obtained from a single reaction for each standard reaction were 
all values that fell within a linear portion of the standard curve.  The obtained Ct 
values from the qRT-PCR experiment were exported to Excel for data analyses.  
Fold change in signals of expression of the genes of interest relative to GAPDH 
and -Actin were determined by using the Ct method.  The results were 
expressed as mean  SD.   
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2.8 Protein quantification and Slot blot assays 
A cell lysate was prepared from the HT29.f8 cells, and quantified using a 
micro-BCA protein assay. Cell lysates (10, 5, 2.5, 1.25 µg) were added to 
nitrocellulose membranes, probed with a 1:1000 dilution of rabbit anti-CNR1/2 
antibodies (Antibodies Online, Atlanta, GA) and reactive bands were visualized by 
the addition and excitation of goat anti-rabbit antibodies Alexa Fluor®546 (Life 
Technologies) using the Typhoon 9500 Plus laser scanner (GE Life Sciences, 
Marlborough, MA). 
3. RESULTS 
Our first experiments using the human RV (Wa) to infect a human intestinal 
cell line, HT29.f8, with A1 or A3 treatments and control cells (no virus, A1 and A3 
only) were performed at 18 hpi. There were ultrastructural differences between 
RV-infected and RV-infected, arachidin-treated cells, including changes in the size 
of mitochondria, PM blebbing, and enlarged nuclei in RV-infected cells (Fig. 1).  
The viability assay of the cells at 18 hpi showed no adverse effects of the 
arachidins (Fig. 2). Also, two populations of RV particles were observed with cells 
collected from all RV treatments (with/without arachidins), enveloped RV particles 
(eRV) and non-enveloped RV particles (neRV) (Fig. 3).  The viroplasm (V), was a 
prominent component in RV-infected cells and is the site where newly formed 
immature eRV particles are assembled and bud into the endoplasmic reticulum 
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(ER). Once eRV particles lose the ER envelope and condense to the neRV form 
they either obtain the VP4 in the ER or at the PM to become mature infectious RV 
particles that are approximately 75-80 nm in diameter (M.K. Estes & Greenberg, 
2013). The plaque forming assays confirmed that the Wa RV strain had similar 
decreases in the production of infectious virus particles at 18 hpi with arachidin 
treatment (Fig. 4).  Furthermore, a shift in the size of the released viral populations 
from neRV to eRV with decreased viral titers with the addition of the arachidins was 
observed using TRPS analysis (Fig. 5 a, b, c). Therefore, a time course study was 
implemented to observe any significant temporal changes at 12, 14, 16 and 18 hpi. 
3.1 Viability of HT29.f8 cells during an RV infection at 18 hpi 
Percent live/dead cells were calculated using the trypan blue exclusion dye 
assay as previously described (Ball et al 2015).  Briefly, at 18 hpi, the cells treated 
with A1, A3, NV, and NV+DMSO all had cell viabilities of at least 93.5%. Cells 
infected with RV alone had a viability of 91.7% and cells with RV and 0.02% DMSO 
had a viability of 91.3% (Fig. 2). RV-infected cells treated with the A1 and A3 
showed an increased viability of 94.5% and 93.7%, respectively.  
3.2 RV particle size measurements with TEM 
From the low magnification micrographs viewed for autophagosome 
content and nucleus to cytoplasm ratios, RV particles of two different populations 
were observed, eRV and neRV (Fig. 3A). Twenty-three RV particles from each 
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group were measured from higher magnification micrographs and the diameter 
expressed as mean ± SD statistical evaluation by analysis of variance (ANOVA) 
demonstrated that eRV and neRV virus particles represented two populations with 
average diameters of neRV 115 nm and eRV 78 nm p = 1.50E-30 (Fig. 3B) 
3.3 Production of infectious virus particles with the addition of A1 and A3 
Supernatants collected at 18 hpi from the RV-infected and RV-infected with 
20 µM concentrations of A1 or A3 were used for plaque forming assays to quantify 
the amount of infectious viral progeny produced (Arnold et al., 2009).  The PFU 
assays demonstrated statistically significant differences between RV and RV+A1 
(p = 2.39E-5) and RV and RV+A3 (p = 2.38E-5); representing 79-fold change 
decrease in PFU with A1 treatment and a 94-fold change decrease in PFU with A3 
treatment (Fig. 4).   
3.4 Quantification of RV particles and size distribution by TRPS analysis 
The concentration of particles in RV-only samples gradually increased to 
2.13E13 particles/mL at 18 hpi (Fig. 5). Also, the particles had a dispersed range 
in diameter until the 16 and 18 hpi time points, when the average particle size was 
74 nm (Fig. 5A).  RV-infected cells treated with A1 displayed a pattern of increasing 
particle concentration over the time course to 1.05E13 particles/mL at 18 hpi.  At 
12 hpi, the RV particles averaged 110 nm in size, but at 14, 16 and 18 hpi a 
scattered distribution was observed with an average diameter of 103 nm (Fig. 5B). 
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Furthermore, RV-infected cells treated with A3 demonstrated a gradual increase 
in particle concentration to 2.01E13 particles/mL at 18 hpi. At 12, 14, and 16 hpi a 
wide range of RV particle sizes were displayed averaging 104 nm; however, at 18 
hpi a shift to a population of larger particles (116 nm) was revealed (Fig. 5C).  
3.5 TEM Analysis of RV-infected HT29.f8 Cells with/without A1/A3 
HT29.f8 cells were infected with RV (Fig. 6 panel 1A-D), RV with A3 (Fig. 6 
panel 2A-D), and RV with A1 (Fig. 6 panel 3A-D).  These were compared to the 
three controls, NV, A3, and A1 (Fig. 6 panel 4A-C). With RV only (Fig. 6 panel 1A-
D), at 12 hpi, RV particles were present and by 14 hpi, and the cytoplasm had 
numerous vesicles present.  By 16 hpi, the nuclei increased in size and by 18 hpi, 
the cells appeared apoptotic with PM blebbing and large nuclei.  RV treated with 
A3 (Fig. 6 panel 2A-D) by 18 hpi, the cells appeared to have normal-sized nuclei 
with numerous vesicles in the cytoplasm.  With the RV treated with A1 (Fig. 6 panel 
3A-D) there were numerous autophagosomes present in the cytoplasm and by 18 
hpi, the nuclei appeared to be similar in size to the control cells. TRPS analysis of 
the extracellular particles was performed and the populations of viral particles by 
size were charted (Fig. 6 panel 5a-c and panel 6a-d).  Particles from RV-infected 
cells demonstrated a wide range in diameter at 12 hpi that narrowed to a range of 
smaller sizes by 18 hpi.  RV-infected cells treated with A3 contained large particles, 
and the diameter range remained consistent throughout the study (Fig. 6 panel 
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5B).  Figure 6 panel 5C represents the diameters of RV particles from RV-infected 
cells treated with A1 from 12 to 18 hpi; RV diameter distribution appeared to 
increase over the time course. 
 TRPS graphs were overlaid for the different treatments at the same time 
points (Fig. 6 panel 6A-D).  At 12 hpi, all three treatments displayed similar 
distributions of their viral particle populations, but by 14 hpi, RV only and RV with 
A1 treated particles began to show a distribution of smaller particles typical of the 
mature form of RV.  By 16-18 hpi, all three treatments revealed different 
distributions of RV particle diameters.  RV only showed a distribution of small 
particles, RV with A1 showed a broad distribution of particle sizes, and the 
distribution of RV particles from A3 treated cells was unchanged from that 
observed at 12 hpi.  Figure 6 panel 7A illustrates the presence of autophagosomes 
in RV-infected cells treated with A1 Figure 6 panel 7B demonstrated a viroplasm 
where immature RV particles were assembled, then released into the ER where 
they acquire the ER membrane envelope. 
At 18 hpi, the ultrastructural appearance and mean nuclear to cytoplasm 
ratios of the control cells with A1 (0.56) and A3 (0.50) were similar to the cells with 
no treatment (0.46) (Fig. 7 E). An increase in the number of mitochondria, 
autophagosomes, RV particles and viroplasms was demonstrated in RV-infected 
cells, and RV-infected cells treated with A1 or A3 (Fig. 7 A-D).   
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At 12 hpi, RV cells had a mean nuclear to cytoplasmic ratio of 0.83 and a 
more apoptotic appearance with rounded nucleus and membrane blebbing 
(Superti et al., 1996).  RV-infected cells treated with A1 exhibited a more normal 
ultrastructure and had a mean nuclear to cytoplasmic ratio of 0.42 (Fig. 7A), 
comparable to uninfected cells at 0.46 (Fig. 7E). Cellular ultrastructure of RV-
infected cells treated with A3 correlated with normal cells; however, the mean 
nucleus to cytoplasm ratio was much smaller at 0.20 (Fig. 7A).  
At 14 hpi, RV-infected cells demonstrated large abnormal mitochondria 
(large, with poorly defined cristae) and increased numbers of vacuoles. 
Additionally, the mean ratio of nucleus to cytoplasm was 0.55 (Fig. 7B) slightly 
reduced from the ratio at 12 hpi (Fig. 7A). However, with the addition of A1, the 
mean nucleus to cytoplasm ratio was increased to 0.91 (Fig. 7B).  RV-infected cells 
treated with A3 at 14 hpi had an average ratio of 0.73 (Fig. 7B) and had a relatively 
normal ultrastructure similar to control cells.   
At 16 hpi, the mean ratio of RV-infected cells was 0.41, similar to the control 
cells (NV, A1and A3 alone) as shown in figure 7C.  At the same time point, RV-
infected cells treated with A1 had a large average ratio of 1.48 (Fig. 7C) and 
displayed a pyknotic ultrastructure often seen in apoptotic cells (Nikoletopoulou, 
Markaki, Palikaras, & Tavernarakis, 2013).  RV+A3 cells had similar ratios at 14 
and 16 hpi (0.73 and 0.77) (Fig. 7B, C). 
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At 18 hpi, the RV-infected cells demonstrated an increased nucleus to 
cytoplasm ratio and apoptotic characteristics as seen in figure 7D (Elmore, 2007).  
RV-infected cells treated with either arachidin had similar mean ratios, 0.41 and 
0.42, respectively, and both A1 or A3 treatments showed normal ultrastructure 
(Fig. 7D).  
3.6 Autophagosome content in RV infected cells present 12-18 hpi 
The time course analysis quantified the number of cells with 
autophagosomes present (n≥ 13 cells/treatment). NV, A1 and A3 only treated 
HT29.f8 cells were compared to RV-infected cells with or without A1 or A3 
treatment (Fig. 8). The percentage of cells that had autophagosomes increased 
over the time course (12, 14, 16, 18 hpi) for RV-infected cells (15%, 27%, 31%, 
and 46%, respectively).  A similar, increasing pattern was observed with the A1-
treated, RV-infected cells at 12, 14, 16 and 18 hpi, displaying 54%, 62%, 82% and 
92% of cells with autophagosomes, respectively (Fig. 8). The percent cells positive 
for autophagosomes with A3-treated, RV-infected cells were similar to the RV-only 
cells, displaying an increase in the number of positive cells to 46% at 16 hpi; 
however, at 18 hpi there was a dramatic decrease to 8% cells (Fig. 8).  Control 
cells (NV = no virus and A3 only) presented 7% and 15% cells positive for 
autophagosome, respectively (Fig. 8). Conversely, 45% of A1-treated cells were 
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positive for autophagosomes, similar to the RV-infected rate at 18 hpi and RV-
infected with A3 at 16 hpi.  
3.7 Quantification of Transcripts for HT29.f8 cells treated with arachidins 
 
Multiple connections exist between autophagy and apoptosis (Dang et al., 
2015; Kroemer & Levine, 2009; Nikoletopoulou et al., 2013; Wanget al., 2015). The 
presence of both pathways as observed with TEM, led to exploration of the 
molecular and functional connections between the apoptosis and autophagy 
pathways in RV-infected HT29.f8 cells with and without the arachidins.  The 
expression of caspases that initiate the apoptosis death pathway (initiator 
caspase-8 and -9) and genes that execute the apoptosis death pathway (caspase-
3 and -7).  Also, we detected the presence of genes (Beclin-1, Bcl-2, atg 3, atg 5) 
that are decisive in the progression to autophagy (Noguchi & Hirata, 2015). In our 
experiments, both initiator caspases (caspase-8 and -9) showed a two-fold 
increase in transcripts with RV infection that was statistically reduced with the 
addition of both A1 and A3 (Fig. 9A and C). Also, two of the executioner caspases, 
cas-3 and cas-7, showed a two-fold increase in transcripts with RV infection that 
was statistically reduced with the addition of A3 (Fig. 9A and C). Likewise, the 
autophagy proteins that are important in the crosstalk between autophagy and 
apoptosis, Beclin-1 and Bcl-2, demonstrated a two-fold increase in transcripts with 
a RV infection that was statistically reduced with the addition of A1 or A3, while 
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ATG-3 and ATG-5 were not significantly affected by RV, A1 or A3 (Fig. 9 B and 
D).  The manipulation of the two death pathways could initiate the regulation of RV 
infection, leading to the observed antiviral activity of A1 and A3. 
3.8 Slot Blot confirmation of the presence of cannabinoid receptors 
The slot blot data confirmed the presence of both cannabinoid receptor 1 
(CBR1) and cannabinoid receptor 2 (CBR2) on HT29.f8 cells (Fig. 10).   
4. DISCUSSION 
Previous experiments using the simian RV, SA11.4f, demonstrated an 
antiviral effect of both A1 and A3 that decreased the amount of released infectious 
RV and suggested a reduction in viral replication (Ball et al 2015). This study 
investigated the effects of A1 and A3 on the clonally derived human intestinal cell 
line, HT29.f8, infected with the human RV strain, Wa.  Time course experiments 
(12, 14, 16 and 18 hpi) were performed to observe the intracellular patterns of the 
host cell and production of RV particles in RV-infected cells with/without the 
arachidins.  At the same time points, the intracellular and extracellular RV particles 
were examined to determine the diameter size of the population. 
 Viability assay data showed that the arachidins did not adversely affect the 
host cells whether they were infected with human RV (Wa) or not (Fig. 2). This 
implies that the arachidins are not toxic to the cells, and that any effects observed 
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in this study can be attributed to the mechanism of action of the arachidins on RV 
and viable HT29.f8 cells.  
TEM analysis of the diameters of the intracellular RV particles revealed two 
distinct populations of particles, neRV and eRV.  Correspondingly, TRPS analysis 
demonstrated varying populations of both neRV and eRV.  The viral titers from RV-
only cells, quantifying the population of extracellular particles, had a large 
population of neRV, whereas viral titers from RV-infected, arachidin treated cells 
were dominated by eRV particles.  Other studies suggest that neRV particles be 
termed infectious due to the shedding of the ER membrane (Ruiz et al., 2009), 
while eRV particles are non-infectious particles (Teimoori et al., 2014).  Verification 
from electron micrographs showed two distinct populations of virus particles 
present in RV-infected cells. eRV representing immature virus and neRV, more 
mature virus particles (Fig.  3A and B) which corresponds to previously reported 
sizes of infectious and noninfectious RV particles (Ruiz et al., 2009; Teimoori et 
al., 2014).  
PFU assays are commonly used to determine titers (PFU/mL) for infectious 
virus particles (Arnold et al., 2012).  Previously, we reported a statistically 
significant change in the amount of infectious RV produced using the simian RV, 
SA11.4f (Ball et al 2015).  This is the first report to demonstrate that the human RV 
(Wa)-infected cells treated with A1 and A3 produced significantly fewer infectious 
RV particles than untreated RV-infected cells (Fig.4). This demonstrates that A1 
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and A3 have antiviral activity against both a simian RV (SA11.4f) and a human RV 
(Wa). 
TRPS analysis showed that early during an RV infection without A1 or A3 
treatment, RV particles averaged 78 nm in diameter, consistent with the neRV 
range, with a wide distribution of diameters in the eRV range as well (Fig. 5A). 
However, as the infection progressed RV particle size was reduced  to a neRV-only 
size distribution with 74 nm diameter average size, similar to that of mature RV 
particles in other studies (Ruiz et al., 2009).  Treatment with A1 caused a decrease 
in viral progeny but broadened the size distribution of RV particles in the eRV 
population, averaging 96 nm (Fig.5B). Similar findings were observed for the A3-
treated, RV-infected cells with a broad distribution of virus particles at 12, 14, and 
16 hpi. Interestingly, at 18 hpi the population was minimized to a diameter within 
the eRV range, 116 nm (Fig. 5C). 
The time course study demonstrated changes in the ultrastructure of the 
RV-infected cells treated with the arachidins.  When comparing RV to RV with A3, 
there appeared to be a 2-hour delay in the appearance of numerous vesicles in 
the cytoplasm.  This was not observed with RV with A1, but with this treatment 
many autophagosomes were seen by 18 hpi.  Apoptotic characteristics were not 
observed in arachidin-treated, RV-infected cells, indicating different pathways 
were regulated by the two arachidins. 
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The RV-infected cells revealed approximately equal amounts of nucleus 
and cytoplasm at 12 hpi, but at 14 to 16 hpi the area of the cytoplasm was twice 
that of the nucleus.  At 12, 14 and 16 hpi, the arachidin treated, RV-infected cells 
followed a different pattern. At 12 hpi, the area of the cytoplasm was twice that of 
the nucleus which changed at 14 and 16 hpi to equal amounts of cytoplasm and 
nucleus. However, there was a dramatic switch by 18 hpi with RV-infected cells 
having a larger nucleus than cytoplasm, and the arachidin-treated, RV-infected 
cells having twice as much cytoplasm as nucleus. This implies that there is a switch 
between 16 and 18 hpi that is regulated by the arachidins, with treated cells similar 
in appearance to uninfected controls (Fig. 7). 
In addition, ultrastructure and morphometric analysis of human RV (Wa)-
infected HT29.f8 cells revealed different cellular alterations at the time points 
observed in this study (12, 14, 16 and 18 hpi).  TEM observations of the 
ultrastructure of the RV-infected cells revealed the appearance of abnormal 
mitochondria, cellular vesicles, and increased nuclear sizes that suggested a 
progression to apoptosis by 18 hpi (Fig. 1 and 7); whereas the arachidin-treated, 
RV-infected cells showed very different patterns over time with more normal 
appearing mitochondria and nuclei by 18 hpi.  The increased presence of 
autophagosomes in A1-treated cells, as compared to A3 treated, (Fig. 8) suggests 
that A1 and A3 have different mechanism of actions.  
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Previous reports have shown that RV infections lead to cell death using the 
apoptosis cellular death pathway (Frias et al. , 2012). However, recent studies 
have suggested that the RV nonstructural protein 4 (NSP4) alone triggers the cells 
to produce autophagosomes, suggesting a change to an autophagy pathway that 
may be arrested at the autophagosomal stage of development (Crawford et al., 
2012). The data presented here show ultrastructural changes in human intestinal 
cells that indicate the apoptosis pathway is activated with an RV infection, and that 
the addition of A1 or A3 causes major changes in the RV-infected cells, leading to 
the absence of apoptotic features and an increase of autophagosomes (Fig. 9 
panel 7A).  More A3 treated cells contained autophagosomes at 16 hpi, followed 
by a dramatic reduction at 18 hpi similar to uninfected cells (Fig. 8).  A different 
pattern was observed in the A1 treatments with 92% of cells positive for 
autophagosomes by 18 hpi, again suggesting that A1 and A3 have different 
mechanisms of action. 
An examination of the effects of the various treatments on the expression 
of apoptosis and autophagy genes important in the modulation of both cell death 
pathways by qRT-PCR demonstrated a significant decrease in apoptosis 
transcripts in RV-infected cells with the addition of either A1 or A3 (Fig. 9 A-D).  
Similarly, a significant decrease in the transcripts for Beclin-1 and Bcl-2 shows a 
regulation of RV-infected cells that can change the outcome of an infection. 
Previous studies observing different infectious agents and host systems have 
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revealed that autophagy and apoptosis can cooperate, antagonize or assist each 
other and affect the fate of the cell, and is well documented that the crosstalk 
between autophagy and apoptosis is mediated, at least in part, by the functional 
and structural interaction between Beclin-1 and the anti-apoptotic proteins BCL-2 
(Nikoletopoulou et al., 2013; Pattingre et al., 2005).  
A previous study demonstrated the binding of A1 and A3 to cannabinoid 
receptors 1 and 2 (Brents et al., 2012).  The presence of these receptors on our 
cells suggests a signaling pathway that could be used in HT29.f8 cells to modulate 
an RV infection. 
Altogether, the data suggests the addition of A1 or A3 to RV infections has 
a protective effect on host cells, and that a crosstalk between apoptosis and 
autophagy inhibits RV morphogenesis.  These findings indicate the possibility that 
RV modulates the switch between autophagy and apoptosis to facilitate their own 
replication in untreated cells, and suggests that A1 and A3 restore cellular 
homeostasis, producing a protective response that has potential therapeutic 
antiviral activity.  
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TABLES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.  cDNA synthesis thermocycler parameters.   
  Temperature  Time  Number of cycles  
cDNA synthesis  42°C 30 min 1 cycle 
Inactivation  95°C 2 min  1 cycle 
 
 
 
Table 3.  PCR cycle conditions used for qRT-PCR.   
 
 
 
 
 
 
 
  
Initial denaturation 94°C  3 minutes 
 PCR (34 cycles) 94°C 30 seconds 
58°C 30 seconds 
72°C 1 minute  
Table 1. cDNA Master Mix. 
  Volume  Final Concentration  
5x cDNA synthesis buffer 4μL 1x 
dNTP Mix 2μL 500μM each 
Anchored oligo dT  1μL   
Verso Enzyme Mix  1μL   
Template (RNA) 5μL 5μg 
Nuclease-free Water  7μL   
Total Volume  20μL   
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Table 4. Primers for autophagy and apoptosis 
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Figure 9. 
Quantification of Transcripts for Apoptosis and Autophagy Genes in HT29.f8 Cells Treated 
with and without Arachidins 
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Figure 10.   
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FIGURE LEGENDS 
Fig. 1. Electron micrographs of rotavirus-infected HT29.f8 cells A) rotavirus (Wa) 
only infected HT29.f8 cells at 18 hpi. Mitochondria (M) and autophagosomes (AP) 
are indicated by arrows. Final Magnification = 7,800x.  B) Rotavirus (Wa) infected 
HT29.f8 cells treated with A3 at 18 hpi. Mitochondria (M), rotavirus particles (RV), 
and a nucleolus (N) are indicated by arrows. Final Magnification = 8,300x. 
Fig. 2. HT29.f8 cell viability assay.  Using a Trypan blue exclusion dye assay, the 
cells were counted in triplicate with and without treatments (DMSO, A1 or A3) at 
18 hpi and percent live/dead cells were calculated. Data was statistically evaluated 
by Student’s 𝑡-tests and expressed as mean ± SD (significance level, 𝑝 ≤ 0.05). 
Fig. 3. Measurement of RV particle sizes.  A) RV-infected HT29.f8 cells with 20µM 
A3 were processed for TEM at 18 hpi. The two different sized RV particles were 
observed and measured to determine the average RV particle diameter.  B) 
Measurements of RV particles in HT29.f8 cells infected with RV at 18 hpi. N=23 
per group. *Statistically significantly different population, p = 1.50E-30.  
Fig. 4. Quantification of infectious Wa RV particles using plaque forming assays 
(PFU/mL) at 18 hpi. HT29.f8 cells were infected with RV, RV+20 µM A1, or RV 
+20 µM A3.  At 18 hpi, the supernatants were collected, clarified by centrifugation, 
and used in plaque forming assays. The RV titer was 8.6E13, RV with A1 titer was 
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1.09E12, and RV with A3 titer was 9.13E11. Statistically analysis showed there 
was a significant difference between RV and RV with A1 (p = 2.39E-5), likewise 
there was a significant difference between RV and RV with A3 (p =2.38E-5). 
Fig. 5. TRPS time course study of arachidin treated HT29.f8 cells. The size 
variations, virus concentrations and population distribution of extracellular RV 
particles were measured from supernatants of RV-infected cells treated 
with/without A1 and A3 at 12, 14, 16 and 18 hpi.  A) Supernatants collected from 
RV-infected cells B) Supernatants collected from RV-infected cells treated with 20 
µM A1 C) Supernatants collected from RV-infected cells treated with 20 µM A3. 
Fig. 6.  Electron microscopic and TRPS time course study of RV-infected HT29.f8 
cells and supernatants treated with and without arachidins. Rows 1-3 are 
micrographs of RV-infected HT29.f8 cells treated with A1 and A3 from 12-18 hpi. 
Control cells (NV, A1, and A3) were collected at 18 hpi and are displayed in panel 
4. Panel 5 and 6 demonstrate TRPS experiments from 12-18 hpi that are overlain 
together.  Autophagosomes (7A) and RV particles exiting a viroplasm into the ER 
(7B) in RV-infected HT29.f8 cells at 18 hpi. 
Fig. 7. Time course analysis of HT29.f8 nuclear to cytoplasm ratio are shown at 
higher magnification using transmission electron microscopy. A) Electron 
micrographs of cells collected at 12 hpi, B) Electron micrographs of cells collected 
at 14 hpi, C) Electron micrographs of cells collected at 16 hpi, D) Electron 
53 
 
 
micrographs of cells collected at 18 hpi, Micrographs collected from control cells 
(NV, A1, A3) at 18 hpi. n = 10 for each treatment. 
Fig. 8. Percent of HT29.f8 cells with autophagosomes over time. RV TEMs (n=13 
for each time point) were compared to the no virus (NV) control.  RV with A1 TEMS 
were compared to the A1 only control, and RV with A3 TEMS were compared to 
the A3 only. 
Fig. 9.  Real-time quantitative PCR (qRT-PCR) investigation of apoptosis and 
autophagy signaling pathways. Total RNA at 8 hpi was extracted from HT29.f8 
cells with RV, RV+20µM A1, RV+20µM A3, 20µM A1 or 20µM A3 at 8 hpi. cDNA 
for each treatment was synthesized and used for qRT-PCR experiments. Fold 
change in expression of the genes of interest relative to GAPDH and β-actin were 
determined using the 2ΔΔCT method. The results are expressed as mean ± SD from 
three separate experiments. 
Fig. 10.  Presence of cannabinoid receptors on uninfected HT29.f8 cells. Cell 
lysates (10, 5, 2.5, 1.25 µg) were added to nitrocellulose membranes, probed with 
a 1:1000 dilution of rabbit anti-CNR1/2 antibodies from Antibodies Online (Atlanta, 
GA) and reactive bands were visualized by the addition and excitation of goat anti-
rabbit antibodies Alexa Fluor®546 (Life Technologies) using the Typhoon 9500 
laser scanner. 
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CHAPTER TWO 
 
 
 
To compare results observed from two cell lines our second study used 
African green monkey kidney cells (MA104) that were infected with human RV, 
Wa, and treated with A1 or A3. Based on results from the first study, experiments 
were conducted at 18 hpi.  
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Abstract 
Rotavirus (RV) causes severe life threatening diarrhea in young children and 
immunocompromised individuals.  Several effective vaccines for young children have 
been developed, but there are no vaccines or antiviral therapeutics for RV infected 
immunocompromised patients of any age.  Our laboratory has discovered a decrease in 
the numbers of infectious RV particles and the RV non-structural protein 4, NSP4, in a 
simian RV-infected human intestinal cell line, HT29.f8, with the addition of either of two 
stilbenoids, arachidin-1 or arachidin-3 (A1 and A3). This suggests effects on both the cells 
and RV replication. This study examined the effects of A1 and A3 using the human RV, 
Wa, to infect the kidney cell line, MA104.  Plaque forming assays measured progeny 
infectious RV particles, and tunable resistance pulse sensing (TRPS) analysis quantified 
RV particles and determined their particle size distribution.  Morphometric analysis of 
the cells was performed using transmission electron microscopy (TEM), and quantitative 
reverse transcription polymerase chain reaction (qRT-PCR) measured specific 
autophagy and apoptosis gene transcripts. Plaque assays demonstrated a decrease in 
infectious RV particles with the addition of A1 or A3. TRPS analysis showed a shift in 
the population of virus particles from an average size of 70nm to 110nm that 
corresponded to non-enveloped and enveloped RV particle sizes, respectively, observed 
with TEM. Likewise, the signs of apoptosis and autophagy observed with TEM, were 
validated with qRT-PCR. This study confirms that RV-infected MA104 cells and progeny 
RV particles are altered with the addition of the A1 or A3.  Furthermore, interactions 
among the genes associated with apoptosis and autophagy suggest complex cross-talk 
between the two pathways. Future studies will further define the cellular pathways 
affected by the arachidins to evaluate their potential broad antiviral activity. 
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Introduction 
Rotaviruses (RV) are members of the Reoviridae family that causes infantile 
gastroenteritis in children less than 5 years of age (Ward, 1996), and severe diseases in 
pediatric and adult immunocompromised individuals (Anderson & Weber, 2004; Bakare et al.,  
2010; Park et al., 2015; Patel et al., 2010; Yin, Metselaar, Sprengers, Peppelenbosch, & Pan, 
2015). There are two licensed RV attenuated vaccines, RotaTeq® (Merck) and Rotarix® 
(GlaxoSmithKline), in the United States that prevent severe diarrhea (Leshem et al., 2014; Yen 
et al., 2014), and an attenuated RV vaccine, Rotavac®, in India (Bhandari et al., 2014).  
However, the vaccines efficacies are dependent on the timing of vaccination, and are designed 
to protect against common RV strains in specific areas of the world (Jiang et al., 2010; Patton, 
2012).  Consequently, they are dependent on the genetic stability of the virus (Patton, 2012), 
but reassortments are common and result in new infectious RV strains (Patton, 2012; Weinberg 
et al., 2013).  Furthermore, the vaccines are contraindicated for immunosuppressed individuals, 
and there are no antiviral therapeutic agents currently available for RV infections.  Besides the 
possibility of contracting RV-induced diarrhea directly from the attenuated vaccines, there are 
documented cases of horizontal transmission of vaccine RV among immunocompromised 
household contacts from vaccinated children who shed the vaccine virus  (Hsieh et al., 2014; 
Patel et al., 2010; Yen et al., 2015) 
RV replication occurs in mature enterocytes of the villi of the small intestine, leading 
to structural and functional changes in the epithelium. RV is transmitted by the fecal-oral route 
and is extremely contagious (Cook et al., 1990). The incubation period is 24 to 48 hours.  
Symptoms consist of watery diarrhea, vomiting, and fever lasting up to 4-8 days (Bernstein, 
2009).  Development of effective antiviral drugs that affect a wide-range of RV strains and 
reduce the burden of disease is an important strategy for the prevention of RV disease, 
especially in immunocompromised individuals. Likewise, the discovery of antiviral 
mechanism(s) that act upon other viruses could lead to the development of an antiviral 
compound with a broad range of activity. 
Our laboratory is investigating the effects of highly purified prenylated stilbenoids 
extracted from peanut (Arachis hypogea) hairy root cultures on RV infections (Ball et al., 
2015). Previously, we tested four stilbenoids, and demonstrated that the two prenylated 
stilbenoids, arachidin-1 (A1) and arachidin- 3 (A3), significantly inhibit the production of 
infectious simian RV (SA114f) virions (Ball, et al., 2015).  Stilbenoids are secondary 
metabolites derived from plants that have antioxidant, anticancer, antifungal and anti-
inflammatory properties, having been shown to have many human health benefits (Aggarwal 
et al., 2004; Athar et al., 2007; Roupe et al., 2006). They are products of the phenylpropanoid/ 
acetate pathway and act as phytoalexins produced by plants such as grapes, berries, and peanuts 
in response to pathogens (Huang et al., 2010; Moss et al., 2013).  
Phytoalexins are antioxidative substances synthesized by plants that accumulate 
rapidly at areas of pathogen infections (Hammerschimidt & Dann, 1999).  Although the 
molecular mechanism(s) of action for A1 and A3 on RV infections are not known, the decrease 
in infectious virus particles suggests an effect on viral replication that corresponds to a 
reduction in the viral nonstructural protein, NSP4, which is critical for viral replication (Ayala-
Breton et al., 2009; Ball et al., 2015).   Earlier studies have demonstrated that other cell lines 
from different tissues activate different pathways with RV infections (Di Fiore et al., 2015; 
Halasz et al., 2008; Gavan et al., 2006; Otto, Reetz, Eichhorn, Herbst, & Elschner, 2015; 
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Saxena et al., 2016; Uzri & Greenberg, 2013). This study investigated the mechanism of 
action(s) of A1 and A3 on the African green monkey kidney cell line, MA104, infected with 
the heterologous human RV strain, Wa.   
Virus plaque forming assays were performed to quantify and compare the amount of 
infectious RV particles produced in human RV Wa-infected MA104 cells with and without A1 
or A3.  Tunable resistive pulse sensing technology (TRPS) using the qNano system by Izon 
was employed to quantify and determine the size distribution of all the virus particles in 
arachidin treated and untreated MA104 cells.  Cellular ultrastructure and gross distribution of 
RV particles was analyzed using transmission electron microscopy (TEM). To corroborate the 
TEM observations, quantitative real time polymerase chain reactions (qRT-PCR) were 
performed using Rhesus macaque (Macaca mulatta)-specific primers for caspase and 
autophagy genes that encode proteins that are essential elements in apoptosis and autophagy 
pathways.  We demonstrate that A1 and A3 decrease the amount of infectious RV particles 
produced, and the population of virus particles is changed from that of enveloped to non-
eveloped particles with arachidin treatments. Also, significant changes in cell structure were 
observed that correspond to the changes in apoptosis and autophagy gene transcripts, induced 
by these compounds suggesting potential anti-RV therapeutic activity of A1 and A3. 
 
Materials and Methods 
Cell lines and virus. 
 
MA104 cells were obtained from ATCC (Rockville, MD) and maintained in Eagle 
Modified Essential Medium (MEM; Gibco, Grand Island, NY) supplemented with 5% fetal 
bovine serum (FBS), glutamine (2 mM), penicillin-streptomycin (100 ug/mL) and non-
essential amino acids (1X) (Sigma, St. Louis, MO).  The cell line was confirmed to be free of 
mycoplasma contamination using the MycoFind mycoplasma PCR kit version 2.0 (Clongen 
Laboratories, LLC).  RV Wa (G[1] P[8] genotype)(Matthijnssens et al., 2008) was amplified, 
viral titers were determined in MA104 cells, followed by storage at -80 °C.  Stilbenoids 
efficacies against RV were tested using MA104 cells. 
 
Bioproduction of stilbenoids in hairy root cultures of peanuts. 
 
To produce the stilbenoids A1 and A3, a previously established hairy root line 3 from 
peanut cv. Hull was used that is capable of synthesizing and secreting A1 and A3 into the 
culture medium upon treatment with the elicitors sodium acetate or methyl-β-cyclodextrin 
(CD) (Cavasol® W7 M)  (Condori et al., 2010; Yang et al., 2015).  A 72-hour treatment of 9 
g/L CD was selected based on the production of the highest levels of A1.  At day nine of the 
hairy root culture, the spent medium from each flask was removed and replaced with elicitation 
medium (fresh MSV medium with 9 g/L methyl-β-CD and incubated in the dark at 28oC for 
an additional 72 h to induce synthesis and secretion of stilbenoids into the culture medium as 
recently described (Abbott et al., 2010; Yang et al., 2015).  After the elicitation period, the 
culture medium was removed from each flask and combined. This pooled medium was mixed 
with an equal volume of ethyl acetate in a separator funnel to extract the stilbenoids as 
described previously (Condori et al., 2010).  The ethyl acetate phase was recovered and was 
dried in a rotavapor (Buchi), and A1 and A3 were purified from the extract by HPCCC as 
follows. The dried ethyl acetate extract was suspended in HPCCC solvent system (hexane:ethyl 
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acetate:methanol:water [4:5:3:3]) and injected into a SpectrumTM (Dynamic Extractions) 
HPCCC system.  HPCCC fractions containing A1 and A3 with over 95% purity based on 
HPLC analysis (UV 340 nm) were combined, dried under a nitrogen stream and used for viral 
assays (Abbott et al., 2010).  As previously demonstrated, A1 and A3 were the major 
stilbenoids present in the culture medium (Ball et al., 2015).   The dry mass of each stilbenoids 
was reconstituted in 0.002% DMSO with 1 µg/mL trypsin (Worthington Biochemical, 
Lakewood, NJ) in MEM medium. 
Viability Assay. 
   
 Viability assays were performed with 0.002% DMSO only (NV + DMSO) that was 
used to solubilize the hydrophobic arachidins (A1 and A3), RV only, RV + DMSO, RV + 20 
µM A1 , RV + 20 µM A3,  20 µM A3,  20 µM A1 and NV (no virus) using the trypan blue 
cell exclusion assay (Ball et al., 2015; Freshney, 1994).  Briefly, MA104 cells were grown to 
80% confluence in 6-well tissue culture plates (Corning Life Sciences), and starved for fetal 
bovine sera 12 hours prior to the addition of DMSO or DMSO with varying concentrations of 
the arachidins. At 18 hours after the addition of the solutions, a suspension of approximately 
106 cells/ml was diluted 1:1 with a 0.4% trypan blue solution, and loaded onto a 
hemocytometer.  The number of stained cells and total number of cells were counted, and the 
calculated percentage of unstained cells was reported as the percentage of viable cells. Each 
treatment was performed in triplicate, and data was expressed as the mean +/-standard 
deviation (SD), and comparisons were statistically evaluated by analysis of variance 
(ANOVA) and Student t tests using Excel (significance level, p ≤ 0.05). 
RV Infection.  
 
 To test the biological activity of the stilbenoids on RV infections, MA104 cells were 
grown to 80% confluence in 6 well tissue culture plates (Corning Life Sciences); starved for 
fetal bovine sera 12 hours prior to infection then infected with RV Wa as previously described 
(Arnold et al., 2009; Ball et al., 2015; Yakshe et al., 2015).  Briefly, Wa RV stock was sonicated 
(5 min using a cup horn attachment and ice bath in a Misonix Sonicator 3000; Misonix, Inc, 
Farmingdale, NY) and incubated in serum-free MEM with 1 μg/mL trypsin (Worthington 
Biochemical, Lakewood, NJ) for 30 min at 37°C. The activated viral inoculum was incubated 
with cells for 1 h at 37°C in 5% CO2 at an MOI of 0.002. The inoculum was replaced with 
serum-free MEM supplemented with 1 μg/mL trypsin and incubated for 18 hpi. The 
supernatants were collected, clarified at 300 x g for 5 min, and stored at -80°C for plaque assays 
and TRPS analysis (see below).  The cells were washed in cold Dulbecco's PBS, 1X (Caisson 
Laboratories, Smithfield, UT), and released from the plates using a 0.25% Trypsin-EDTA 
Solution (1X) (Caisson Laboratories, Smithfield, UT).  After the addition of MEM with 5% 
FBS, the cells were suspended in cold PBS and dilutions were prepared for live/dead cell 
counts (see above in Viability Assays). Cells were washed with PBS and incubated in Modified 
Eagle’s Medium and trypsin (1µg/ml) without Fetal Bovine Serum for 18 hours at 37ºC in 5% 
CO2 (Arnold et al., 2009; Ball et al., 2015; Yakshe et al., 2015).  Supernatants were collected 
and used for TRPS and PFU assays. Some of the cells were fixed with 5% glutaraldehyde for 
TEM analysis as described below.  
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Infectious RV quantification. 
 
PFU assays were performed in triplicate as previously described (Arnold et al., 2009; 
Ball et al., 2015; Yakshe et al., 2015).  Briefly, ten-fold dilutions of RV alone and RV with 
0.002% DMSO and 20 µM A1 or A3 were added to the serum starved MA104 cells for one 
hour infection as described above. The virus inoculum was replaced with 3 mL of a medium 
overlay (1:1 mixture of 1.2% agarose [Apex Low Melting Point Agarose, Genesee Scientific 
Inc] and complete MEM containing 0.5 μg/mL trypsin and incubated at 37°C in 5% CO2 for 3 
to 4 days or until plaques became visible.  A neutral red overlay (1:1 mixture of 1.2% agarose 
with an equal volume of serum-free MEM containing 50 μg/mL neutral red) was prepared and 
2 mL per well of stain overlay was added on top of the first agarose/medium overlay. The six-
well plates were incubated at 37°C until plaques were visible (approximately 12 to 72 h).  The 
individual plaques were counted, and the titers were calculated as follows:  Number of plaques 
x 1/dilution factor x 1/ (mL of inoculum) = PFU/mL.  Plaque forming assays were performed 
in triplicate with data are expressed as mean +/-SD.  Comparisons were statistically evaluated 
by analysis of variance (ANOVA) and Student t tests using Excel (significance level, p ≤ 0.05). 
Quantification and Size Distribution of RV Particles. 
 
To determine the concentration and size of RV particles in the samples (RV, RV+A1 
and RV+A3), TRPS analysis using the qNano system (Izon Science, Cambridge, MA) was 
employed.  TRPS is based on a coulter counter that is composed of two fluid reservoirs filled 
with an electrolyte or other conductive media and separated by a membrane containing a pore 
(Kozak et al., 2011; Weatherall et al., 2016).  When an electrical field is applied across the 
pore, the resistance to the resulting ionic current is indirectly proportional to the cross-sectional 
area of the pore.  When a non-conducting particle passes through the pore, the increase in 
resistance is proportional to the particle volume relative to pore size. This change in resistance 
is detected as a pulse in an ionic current. The pulse frequency is proportional to particle flow 
rate and particle concentration (DeBlois, 1970). This system provides a quick and accurate 
way to measure individual sizes of nanoparticles and their volume in a solution. All qNano 
experiments were performed using the manufacturer's established protocols (Bo et al., 2014; 
Jones, 2015; Vogel et al., 2011).   Briefly, prior to measuring, samples were purified using a 
qEV size exclusion column from Izon, and were then suspended in PBS with 0.025% Tween 
20 to reduce aggregation. A dilution of 1:1000 was placed on the qNano size-tunable nanopore 
(NP100, Izon) with particles detected one at a time as a transient change in the ionic current 
flow. This was denoted as a blockade event with its amplitude representing the blockade 
magnitude.  Because the blockade magnitude is proportional to the particle size, accurate 
particle sizing was achieved after calibration with particles of a known size (CPC100B, Izon) 
using identical settings. The size distribution and concentration analysis was performed using 
IZON proprietary software v3.2.2.268 (Izon).  
Morphometric analysis of RV-infected MA104 cells. 
 
TEM analysis was performed on RV-infected MA104 cells to visualize the effects of 
the A1 and A3 on progeny virus and cellular morphology. Samples were prepared as described 
by Wright (2000).  Briefly, RV-infected MA104 cells with and without 20µM A1 or A3 were 
incubated for 18 hpi, washed with PBS and then trypsinized.  Cells were pelleted and fixed 
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with 5% glutaraldehyde overnight at 4⁰C. The cells were post-fixed with 2% osmium tetroxide, 
dehydrated with a graded ethanol series, infiltrated and embedded in epoxy resin. Thin sections 
were stained with uranyl acetate and lead citrate and were examined with a Hitachi H-7000 
electron microscope operating at 75KeV. Negatives were digitized at 800 dpi and analyzed 
using Macnification Version 2 (Orbicule, Inc., www.orbicule.com ). The mean ratio of the cell 
nucleus: cytoplasm was determined using twelve micrographs of each treatment, and the data 
was graphed for comparisons between tests and control groups. 
Quantification of apoptosis and autophagy gene transcripts. 
  
The PureLink RNA Mini Kit (Ambion by Life Technologies; Foster City, CA) was 
used to extract and purify total RNA according to the manual protocol (Chirgwin et al., 
1979),(Vogelstein & Gillespie, 1979).   Briefly, an equal volume of 70% ethanol was added to 
5µg of total RNA for each sample, and vortexed. The samples were then transferred to a spin 
cartridge and centrifuged for 15 seconds at 12,000xg at room temperature. The sample was 
then washed and centrifuged with 700 μL of wash buffer I for 15 seconds at 12,000xg.  A 
second wash was performed with 500 μL of wash buffer II for 15 seconds at 12,000xg. A final 
spin was performed at 12,000xg for 2 min to dry the membrane containing the bound RNA. 
The RNA was eluted from the membrane with 50 μL of nuclease free water. Total RNA was 
analyzed using a full spectrum analysis at 240nm-320nm using the Cary 50 spectrophotometer 
(Agilent, Corp.). The pure RNA was stored at -80C for future studies. A conversion factor of 
40 μg/mL was used to convert the A260 to concentration and the value of 10 corrected for a 
path length of 0.1 mm (Sean and Wiley, 2008). The concentration of RNA was calculated using 
the formula as follows: Concentration of RNA= A260 x 40 μg/mL x 10 x Dilution factor.  
cDNA was then synthesized from each experimental set using the Thermo Scientific Verso 
cDNA Synthesis Kit using five micrograms of purified total RNA.  A Master Mix was prepared 
as described in the manufacturer’s protocol as shown in table 1.  The samples were then placed 
into the BioRad Real-Time System C1000 Thermal Cycler Instrument (Hercules, California) 
for the following cycle (table 2). The qRT-PCR experiment was performed using a CFX96 
Touch Real-Time PCR Detection System (BioRad).  For all experiments, reactions were 
performed in triplicate with Apex qPCR GREEN Master Mix without ROX (Genesee 
Scientific, San Diego, California) that contained all necessary components to perform a DNA-
binding dye base real-time DNA amplification experiment (Table 3).  Primers were purchased 
from Sigma-Aldrich (St. Louis, MO) with the sequences shown in Table 4.  Each reaction 
mixture contained 10l of Apex qPCR GREEN Master Mix, 0.5l of 10M forward/reverse 
primers, 3l of 50ng template cDNA and nuclease-free water to a final volume of 20l.  
GAPDH and -actin were used as housekeeping genes for relative gene expression analyses. 
The cycle threshold (Ct) value or cycle number obtained from single reactions for each 
standard reaction were all values that fell within a linear portion of the standard curve.  The 
obtained Ct values from the qRT-PCR experiment were exported to Excel for data analyses.  
Fold change in signals of expression of the genes of interest relative to GAPDH and -Actin 
were determined using the Ct method.  The results are expressed as mean  SD.   
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Results 
Viability of MA104 cells in the presence of DMSO, A1 and A3.  
The percentage of live/dead cells calculated using the trypan blue exclusion dye assay 
(Ball et al., 2015).  RV-infected cells showed an average viability of 89.4% demonstrating, a 
viral effect on the cells; RV with 0.002% DMSO showed 91.5% cell viability.  Untreated cells 
(NV) containing 0.002% DMSO showed 97.5% and NV alone demonstrated 93% viability. 
Cells treated with RV + 20 µM A1 displayed a viability of 90% and 20 µM A1 alone had a 
91.3% viability.  Cells treated with RV + 20 µM A3 displayed a viability of 92.5% and 20 µM 
A3 alone had a 95.8% viability (Figure 1).   
The effects of A1 and A3 on the production of infectious RV particles.  
Supernatants were collected at 18 hpi from the RV-infected and RV-infected with 
20µM concentrations of A1 or A3 and used for plaque forming assays.  Plaques were counted 
and the average of three experiments was calculated and graphed as PFU/mL (Figure 2).  Data 
are expressed as mean +/-SD, and comparisons were statistically evaluated by analysis of 
variance (ANOVA) and Student t tests using Excel (significance level, p ≤ 0.05). The PFU 
assays demonstrated no statistical difference between RV and RV with DMSO (p = 0.631).  
The A1 and A3 experiments demonstrated one hundred twenty-seven and one hundred twenty-
fold differences, respectively, from the RV only that were statistically significant (p = 0.014 
for both A1 and A3).  Correspondingly, A1 and A3 demonstrated one hundred thirty-six and 
one hundred thirty-one-fold differences, respectively, from RV with DMSO that were 
statistically significant (p = 0.006 for both A1 and A3) (Figure 2). This suggests that by 18 hpi, 
a large amount of infectious RV is released into the media from RV infected cells, but there is 
a significant decrease in the released infectious RV with the addition A1 or A3. 
TEM morphometric analyses of MA104 cells. 
Morphometric analyses of uninfected, A1 and A3 only treated MA104 cells were 
compared to RV infected cells as well as infected cells treated with A1 or A3.  The ratio of 
nucleus to cytoplasm was calculated using twelve representative cells from each treatment.  At 
18 hpi, the mean ratios of the control cells treated with A1 (0.44) and A3 (0.39) were similar 
to those of the cells with no treatment (0.48) (Figure 3). The RV-infected cells demonstrated 
an increased nucleus to cytoplasm ratio as well as plasma membrane blebbing, both of  which 
have been described as apoptotic characteristics (Elmore, 2007).  RV-infected cells treated 
with A1 and A3 had mean ratios, 0.49 and 0.54 respectively, that were like the ratios of the 
control cells.  However, both arachidin treated RV infected cells displayed different 
ultrastructure characteristics from the control cells.  RV-infected cells treated with A1 had 
many autophagosomes and large sized mitochondria, while the A3 treated cells exhibited many 
small mitochondria and many vesicles in the cytoplasm (Figure. 3). 
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RV particle size measurements with TEM. 
 
RV particles of two different populations were seen at 18hpi, enveloped RV particles 
(eRV) and non-enveloped RV particles (neRV) (Fig.ure 4A). To determine an accurate size of 
the particles, micrographs were taken at high magnification, and twenty-two RV particles from 
each group were measured. Data was expressed as mean +/-SD, and statistically evaluated by 
analysis of variance (ANOVA) to be two significantly different populations (p = 1.96E-31), 
eRV and neRV, with average diameters of neRV 112.74nm and eRV 72.39nm, respectively 
(Figure 4B). 
Autophagosome content in RV infected MA104 cells. 
MA104 cells from each treatment (n = 12 each) were scored positive or negative for 
the presence of autophagosomes.  Control treatments showed autophagosomes in 23.1% of the 
NV cells, 8.3% of the A3 treated cells, and 66.7% of the A1treated cells (Figure 5). 
Comparatively, 5.9% of RV-infected cells were positive, 84.6% of RV-infected cells treated 
with A1 were positive for, and 7.7% of RV-infected cells treated with A3 were positive for 
autophagosomes (Figure 5). 
Quantification of RV particles and size distribution by TRPS analysis. 
TRPS analysis was performed on the RV infected cell supernatants to display the 
concentration of virus particles/mL, diameter of RV particles and size distribution of particles. 
TRPS allow for high-throughput single particle measurements as virus particles are driven 
through pores, one at a time, causing a blockade event that can be measured for individual size; 
the number of blockades is used to determine concentration (Vogel et al., 2011).  The RV only 
samples showed a concentration of 1.71E13 particles/mL at 18hpi (Figure 5A). Also, the 
particles had a dispersed range in diameter from approximately 60-120nm. At the same time, 
RV-infected cells treated with A3 demonstrated particles with diameters between 90-140nm 
(Figure 6B).  Additionally, RV-infected cells treated with A1 displayed a concentration of 
1.42E12, and the particles were between 70-150nm (Figure 6C).  
Quantification of Transcripts for Apoptosis and Autophagy Genes MA104 treated with 
Arachidins. 
Multiple connections exist between autophagy and apoptosis (Dang et al., 2015; 
Kroemer & Levine, 2009; Nikoletopoulou et al., 2013; Wang et al., 2015). This data led us to 
explore the molecular and functional connections between the apoptosis and autophagy 
pathways in RV infected MA104 cells with and without the arachidins. We focused on the 
expression of caspases that initiate the apoptosis death pathway (initiator caspases 8 and -9) 
and genes that execute the apoptosis death pathway (caspase -3 and 7).  Also, we detected the 
presence of autophagy genes (Beclin-1, Bcl2, atg3, atg 5) that are decisive in the progression 
to autophagy (Noguchi & Hirata, 2015).  In our experiments, there was no significant changes 
in the regulation of either the apoptosis or autophagy pathways with the addition of A1 and A3 
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(Figure 7A –D). This demonstrates that at 8 hpi, the two death pathways are not regulating an 
RV infection in MA104 cells. 
Immunoblot assays to detect cannabinoid receptors.  
Slot blot assays were performed to confirmed the presence of both A) cannabinoid 
receptor 1 (CBR1) and B) cannabinoid receptor 2 (CBR2) on MA104 cells (Figure 8).  Both 
uninfected cell lysates (Figure 8 lane 1) and RV-infected cell lysates (Figure 8 lane 2) were 
positive for both receptors.  
Discussion 
Previous studies in our lab using a simian RV, SA11.4f, revealed that A1 and A3 
generate antiviral effects by reducing the amount of released infectious RV particles, 
suggesting a decrease in viral replication (Ball et al., 2015).  This is the first study to investigate 
the A1 and A3 induced changes in a human RV (Wa) infected African green monkey kidney 
cell line, MA104. 
The viability assay verified no adverse effects on the survival of MA104 cells treated 
with both arachidins (A1 and A3), therefore 20µM concentrations of A1 and A3 are not toxic 
to MA104 cells. Any alterations in patterns observed in RV-infected cells treated with the 
arachidins can be attributed to effects of the arachidins on RV and viable host cells.  
Furthermore, the decreased amount of infectious RV produced in Wa-infected 
arachidin treated cells corresponds to the decreases in progeny RV produced in the simian RV, 
SA11.4f, infected human intestinal cell line, HT29.f8 (Ball et al., 2015) with arachidin 
treatments. This indicates that A1 and A3 have antiviral properties that effect both simian and 
human RV strains.   
Morphometric examination of intracellular RV particles demonstrated two size 
populations that corresponded to the sizes of extracellular RV particles measured using TRPS 
analysis.  This indicates that immature noninfectious large RV particles are released from the 
infected cells.  Furthermore, even though the number of extracellular particles detected among 
treatments with and without arachidins were similar, the size distribution of particles varied 
significantly. Additionally, RV-infected, arachidin treated samples released RV particles that 
were the same size as the immature, non-infectious, large particles with ER membrane 
envelopes (eRV) observed in previous studies (Teimoori et al., 2014).  Likewise, RV only 
samples released a distribution of smaller, noneveloped particles (neRV)  that are the size of 
mature infectious RV(M.K. Estes & Greenberg, 2013).  
MA104 cells infected with RV only demonstrated characteristics of apoptotic cells which was 
altered with the addition of A1 or A3 demonstrating an increased nuclear size and membrane blebbing 
seen in previous studies (Nikoletopoulou et al., 2013).  This suggests that the apoptosis pathway was 
regulated by A1 and A3.  Additionally, many autophagosomes were present in the cells with A1 alone 
and RV with A1, which suggested the autophagy pathway was initiated with A1 treatments.  Autophagy 
is a conserved mechanism that produces autophagosomes to degrade damaged proteins in the cytoplasm 
and is believed to be a pro-survival pathway (Noguchi & Hirata, 2015).  Observations of increased 
numbers of autophagosomes in A1 treated cells suggests that A1 modulates an RV infection by 
stimulating cells to utilize the autophagy cell death pathway.  This observation led us to examine the 
apoptosis and autophagy gene transcript by qRT-PCR to confirm the involvement of these pathways in 
the modulation of the RV infection.  However, no significant changes in the gene transcripts were 
observed at 8 hpi from the treated MA104 cells (RV, RV with A1, RV with A3, A1 only and A3 only). 
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This finding is contradictory to data obtained using the same treatments at 8 hpi in a human intestinal 
cell line, HT29.f8 (Parr laboratory, personal communications), suggesting that two cell types use 
different signaling pathways, or have differences in the timing of regulation of apoptosis and autophagy.  
Further studies will be performed to answer this question.   
A previous study has confirmed the binding of A1 and A3 to cannabinoid receptors 1 and 2 
(Brents et al., 2012).  The presence of these receptors on MA104 cells suggests a signaling pathway 
that could be used to modulate an RV infection. This will be further investigated to determine the 
signaling pathways used in RV-infected MA104 cells treated with A1 or A3. 
In summary, data collected from RV-infected MA104 cells treated with A1 or A3 exhibited a 
more normal ultrastructural appearance than untreated infected cells, as well as a decrease in the number 
of extracellular infectious RV particles with a shift to larger, immature, eRV particle size. However, the 
fact that A1 produced numerous autophagosomes while A3 did not infers that different mechanisms of 
action modulate an RV infection, thus broadening the anti-RV therapeutic potential of the arachidins. 
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Tables 
 
 
 
 
 
 
Table 2.  cDNA synthesis thermocycler parameters.   
  Tempeture  Time  
Number of 
cycles  
cDNA synthesis  42°C 30 min 1 cycle 
Inactivation  95°C 2 min  1 cycle 
 
 
Table 3.  PCR cycle conditions used for qRT-PCR.   
  
Initial denaturation 94°C  3 minutes 
 PCR (34 cycles) 94°C 30 seconds 
58°C 30 seconds 
72°C 1 minutes  
Table 1. cDNA Master Mix. 
  Volume  
Final 
Concentration  
5x cDNA synthesis buffer 4μL 1x 
dNTP Mix 2μL 500μM each 
Anchored oligo dT  1μL   
Verso Enzyme Mix  1μL   
Template (RNA) 5μL 5μg 
Nuclease-free Water  7μL   
Total Volume  20μL   
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Table 4. Primers used for the amplification of MA104 apoptosis and autophagy genes 
 
 
 
 
 
 
  
AGGTATCCATGGAGAACACTGA 45.45 62.3 210
CTGTACCAGACCGAGATGC 60 60.9
GGTGGATGCTAAGCCAGA 55 61.5 230
CGAACACCCATACCTGTCA 50 62.1
GGTCACTTGAACCTTGGGA 52.7 62.6 146
TGGGATGCAGTCCAGG 62.5 62.1
ACGGCAGAAGTTCACATTG 47.4 61.4 147
ACACCCAGACCAGTGGAC 61.2 61.2
TABLE 4. Primers used for the amplification of MA104 caspases 3, 7, 8, 9, GAPDH, β-
actin, BCL2, ATG3, ATG5, and BCLN1 RNA by qRT-PCR 
a-Primer sequences obtained from the NCI Primer data base. All oligonucleotides were ordered from Sigma-
Genosys (Sigma-Aldrich Corp).
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FIGURE LEGEND 
 
Fig. 1.  MA104 cell viability assay.  Using Trypan blue exclusion dye, the cells were counted 
in triplicate with and without treatments at 18hpi and percent live/dead cells were calculated. 
Data are expressed as mean ± SD, and comparisons were statistically evaluated by Student’s 
𝑡-tests using Excel (significance level, 𝑝 ≤ 0.05). 
 
Fig. 2.  Plaque forming assays using supernatants from RV-infected and arachidin treated 
MA104 cells.  MA104 cells were infected with a human RV (Wa) treated with/without A1 or 
A3. The inoculum was replaced with serum-free DMEM supplemented with 1 μg/mL trypsin.  
At 18hpi, the cells & media were collected, centrifuged, and stored at -80°C. To titer the RV 
from the supernatants, MA104 cells were incubated with serial dilutions of the test samples & 
plaque forming assays were used to determine the number plaque forming units (PFU/mL). * 
Comparison on RV only to RV + A1, p = 0.014.  ** Comparison of RV to RV + A3, p = 0.014 
*** Comparison on RV + DMSO to RV + A1, p = 0.006 **** Comparison of RV + DMSO to 
RV + A3, p = 0.006. 
 
Fig. 3.  Morphometric analysis of RV-infected MA104 cells treated with and without 
arachidins at 18 hpi. Cells were collected and processed for TEM analysis and the nucleus and 
whole cell were measured with Macnification (Orbicule, Inc). Nucleus to cytoplasm ratios 
were obtained and compared for 10 cells of each treatment.  
 
Fig. 4. RV particle size populations.  A) Transmission electron micrograph (TEM) of Wa 
rotavirus infected MA104 cells at 18hpi). Final Magnification = 57,000x. Endoplasmic 
reticulum (ER), Viroplasm (V), Enveloped virus particles (E), and non-enveloped virus 
particle (NE). B)  Measurements of RV particles in TEM micrographs of MA104 cells infected 
with Wa rotavirus at 18 hpi, n = 22 per group. Statistically significant p = 1.96E-31. 
 
Fig. 5. Percent MA104 Cells with Autophagic Vesicles at 18 hpi.  The presence of 
autophagosomes in the cytoplasm of RV and RV treated cells were scored and compared to 
the three controls, NV, A1 and A3 only.   The percent positive cells (n=12 for each treatment) 
were calculated and graphed. 
Fig. 6.  TRPS analysis of arachidin treat MA104 cells. The size variations, virus concentrations 
and population distribution of extracellular RV particles were measured from supernatants of 
RV-infected cells treated with/without A1 and A3 at 18 hpi.  A) RV-infected supernatants, B) 
Supernatants from RV-infected cells treated with 20µM A3, and C) Supernatants from RV-
infected cells treated with 20µM A1. 
Fig.7.  Real-time quantitative PCR (qRT-PCR) data for gene transcripts in apoptosis and 
autophagy signaling pathways. Total RNA was extracted from MA104 cells with RV, 
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RV+20µM A1, RV+20µM A3, 20µM A1 or 20µM A3 at 8 hpi. cDNA for each treatment was 
synthesized and used for qRT-PCR experiments. Fold change in expression of the genes of 
interest relative to GAPDH and β-actin were determined using the 2ΔΔCT method. The results 
are expressed as mean ± SD from three separate experiments. 
Fig. 8.  Cannabinoid Receptors 1 & 2 on MA104 cells. MA104 cell lysates [1-uninfected and 
2-RV-infected (Wa)] were added to nitrocellulose membranes, probed with a 1:1000 dilution 
of rabbit anti-CBR1 (A) or anti-CBR-2 (B) antibodies from Antibodies Online (Atlanta, GA) 
and reactive bands were visualized by the addition and excitation of goat anti-rabbit antibodies 
Alexa Fluor®546 (Life Technologies) using the Typhoon 9500 Plus laser scanner. 
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CONCLUSIONS 
Historically, rotavirus (RV) infections have been shown to be detrimental to host cells 
due to increased cellular stress that can lead to several cell death pathways, including 
apoptosis (Payne et al., 2012). In a previous study, simian RV-infected human 
intestinal cells (HT29.f8) exhibited a  decrease in the production of infectious RV that 
suggested a decrease in viral replication when treated with A1 or A3 (Ball et al., 2015). 
This implies that the arachidins have an effect on the cells and the RV particles.  To 
identify the effects of the arachidins on RV-infected cells, two cell lines, the African 
green monkey kidney cell line (MA104) and the human intestinal cells (HT29.f8), were 
infected with a human RV, Wa, and treated with A1 or A3.  At 18 hpi, progeny 
infectious RV particles along with host cell ultrastructure were altered with the addition 
of the arachidins, thus indicating that the arachidins have antiviral activity against the 
human strain in both cell lines.  
The production and release of infectious RV progeny decreased when both 
MA104 and HT29.f8 cells were treated with A1 and A3. Also, intracellular RV particles 
were measured and shown to have similar diameters representing two populations of 
particles [enveloped (eRV) and nonenveloped (neRV)] in both cell lines. Furthermore, 
at 18 hpi, the populations of extracellular particles released from RV-infected cells 
exhibited similar diameters to the intracellular particles. This suggests that the smaller 
neRV population represents infectious RV particles. However, at 18 hpi, the 
extracellular population identified from RV-infected cells with A3 were of a larger size 
(eRV), consistent with that of more immature noninfectious particles.  At the same time 
point, the extracellular population identified from RV-infected cells with A1 were broad 
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in sizes ranging from the smaller more mature particles neRV to a larger size (eRV), a 
more immature noninfectious population of particles.    
Likewise, at 18 hpi, both cell lines demonstrated similar ultrastructural 
characteristics of apoptosis which appeared to be regulated to a more normal state 
with the addition of the arachidins.  In addition, A1 treated cells presented increased 
numbers of autophagosomes, suggesting an initiation of autophagy, a pro-survival 
pathway that degrades and recycles damaged proteins and organelles when exposed 
to cellular and metabolic stress (Noguchi & Hirata, 2015).  
To further explore the regulation of the apoptosis and autophagy death 
pathways, gene transcripts representing both pathways were quantified.  HT29.f8 cells 
demonstrated an upregulation of the apoptosis genes and two autophagy genes (Bcl-
2 and Beclin-1) which were significantly decreased with the addition of either A1 or 
A3. This indicates a cross-talk between the pathways is modulated in the presence of 
the arachidins in the human intestinal cell line at 8 hpi. However, we detected no 
regulation of either pathway during RV infection in MA104 cells at 8hpi. This implies 
that the cells use different mechanisms of action to achieve a reduction in infectious 
RV particles at 18 hpi or that there is a different temporal regulation of these cell death 
pathways in MA104 cells. 
Gathered from this data we can conclude that, even without the regulation of 
apoptosis and autophagy transcripts in the MA104 cells, the arachidins play a 
significant role in regulating RV infections by decreasing the amount of virus produced 
and preserving host cell ultrastructure, advocating the need to look further at the 
progression of an RV infection to learn more about the antiviral capabilities of the 
arachidins.  
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The HT29.f8 study employed time course experiments to observe RV 
production and host cell ultrastructure over the course of an infection treated with 
arachidins.  Morphological changes in cell ultrastructure were seen from 12-18 hpi that 
revealed a progression to apoptosis by 18 hpi in RV infected cells while RV-infected 
cells treated with either arachidin exhibited an increase in nuclear size that returned 
to normal by 18 hpi. Interestingly, between 16 and 18 hpi, a switch was observed in 
nucleus to cytoplasm ratios between the RV only cells and those treated with 
arachidins.  This data shows an important time point where the arachidins are 
triggering a change in the host cell. Moreover, throughout the time course, the number 
of cells with autophagosomes increased with the addition of A1 but not with A3. This 
suggest A1 and A3 employ different mechanisms of action. 
Analysis of the extracellular RV particles released from 12-18 hpi from RV-
infected HT29.f8 cells demonstrated a concentration of a broad RV particle size range 
to particles that correspond to neRV seen intracellularly, but A1 treatments produced 
particles that ranged in size from eRV to neRV.  Conversely, A3 treated cells displayed 
a more focused group of eRV particles, suggesting that particles released from these 
treatments did not mature completely before leaving the cell.  Taken together, 
both studies demonstrated ultrastructural regulations of apoptosis with both 
arachidins, the initiation of autophagy with A1 treatments, and a decrease in RV 
production with either arachidin with a shift in RV population to a more immature size. 
Future studies will explore the receptors on host cells to discover how the arachidins 
enter or start a signaling pathway in the cells.  Collectively, RV infections have been 
differentially modulated with the arachidins in cell lines from two different tissues and 
two different species. Further studies will be performed to identify the mechanisms of 
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actions and temporal regulation of the arachidins as their potential development as 
broad acting anti-RV therapeutics is explored. 
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